Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 87

1.

Prions: a piece of the puzzle?

Lahiri DK.

Science. 2012 Sep 7;337(6099):1172. doi: 10.1126/science.337.6099.1172-a. No abstract available.

PMID:
22955815
2.

Cell biology. A unifying role for prions in neurodegenerative diseases.

Prusiner SB.

Science. 2012 Jun 22;336(6088):1511-3. doi: 10.1126/science.1222951. No abstract available.

3.

[Biochemistry of conformational transition and aggregation of amyloid proteins].

Yanagawa H, Ogawa Y.

Uirusu. 2001 Dec;51(2):163-70. Review. Japanese. No abstract available.

4.

A transmembrane form of the prion protein in neurodegenerative disease.

Hegde RS, Mastrianni JA, Scott MR, DeFea KA, Tremblay P, Torchia M, DeArmond SJ, Prusiner SB, Lingappa VR.

Science. 1998 Feb 6;279(5352):827-34.

5.

Spongiform encephalopathies and prions: an overview of pathology and disease mechanisms.

Fairbairn DW, Thwaits RN, Holyoak GR, O'Neill KL.

FEMS Microbiol Lett. 1994 Nov 1;123(3):233-9. Review.

PMID:
7988907
6.

London meeting explores the ins and outs of prions.

Kingman S.

Science. 1993 Oct 8;262(5131):180-1. No abstract available.

PMID:
8105534
7.

Putting prions to the test.

Mestel R.

Science. 1996 Jul 12;273(5272):184-9. No abstract available.

PMID:
8668995
8.

The prion theory: background and basic information.

Riesner D.

Contrib Microbiol. 2001;7:7-20. Review. No abstract available.

PMID:
11923938
9.

Prions: infectious proteins with genetic properties.

Ter-Avanesyan MD, Kushnirov VV.

Biochemistry (Mosc). 1999 Dec;64(12):1382-90. Review.

10.

[Prions--still an enigma of molecular biology? (II)].

Israil A.

Bacteriol Virusol Parazitol Epidemiol. 1996 Jul-Dec;41(3-4):87-98. Review. Romanian. No abstract available.

PMID:
9116407
11.

Neurodegeneration. Could they all be prion diseases?

Miller G.

Science. 2009 Dec 4;326(5958):1337-9. doi: 10.1126/science.326.5958.1337. No abstract available.

PMID:
19965731
12.

Deadly conformations--protein misfolding in prion disease.

Horwich AL, Weissman JS.

Cell. 1997 May 16;89(4):499-510. Review. No abstract available.

13.

[Prions and transmissible neurodegenerative diseases].

Domínguez García A, Mata Albert E, Salleras Sanmartí L.

Med Clin (Barc). 1998 May 30;110(19):751-7. Review. Spanish. No abstract available.

PMID:
9672870
14.

Newly defined toxic α-helical prion protein monomer: implications for other neurodegenerative diseases?

Lasmézas C, Zhou M.

Expert Rev Proteomics. 2012 Jun;9(3):233-5. doi: 10.1586/epr.12.26. No abstract available.

PMID:
22809201
15.

Biomedicine. An end to the prion debate? Don't count on it.

Couzin J.

Science. 2004 Jul 30;305(5684):589. No abstract available.

PMID:
15286333
16.

Cellular Models for the Study of Prions.

Holmes BB, Diamond MI.

Cold Spring Harb Perspect Med. 2017 Feb 1;7(2). pii: a024026. doi: 10.1101/cshperspect.a024026. Review.

PMID:
27815306
17.

Shattuck lecture--neurodegenerative diseases and prions.

Prusiner SB.

N Engl J Med. 2001 May 17;344(20):1516-26. Review. No abstract available.

18.

Prions at the crossroads: the need to identify the active TSE agent.

Nandi PK.

Bioessays. 2004 May;26(5):469-73.

PMID:
15112226
19.

[Molecular pathogenesis of spongiform encephalopathy].

Aguzzi A, Maddalena A, Brandner S, Klein M.

Pathologica. 1997 Oct;89(5):481-90. Review. Italian. No abstract available.

PMID:
9489393
20.

Perspectives on prion biology, prion disease pathogenesis, and pharmacologic approaches to treatment.

DeArmond SJ, Prusiner SB.

Clin Lab Med. 2003 Mar;23(1):1-41. Review.

PMID:
12733423

Supplemental Content

Support Center